Aptitude Software Group (APTD) Competitors GBX 267 0.00 (0.00%) As of 08/15/2025 11:51 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock APTD vs. FBT, GBG, IMO, NCC, CER, ATG, IQG, IDOX, BIG, and ACSOShould you be buying Aptitude Software Group stock or one of its competitors? The main competitors of Aptitude Software Group include First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT), GB Group (GBG), IMImobile (IMO), NCC Group (NCC), Cerillion (CER), Auction Technology Group (ATG), IQGeo Group (IQG), IDOX (IDOX), Big Technologies (BIG), and accesso Technology Group (ACSO). These companies are all part of the "software - application" industry. Aptitude Software Group vs. Its Competitors First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation GB Group IMImobile NCC Group Cerillion Auction Technology Group IQGeo Group IDOX Big Technologies accesso Technology Group Aptitude Software Group (LON:APTD) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Which has better valuation and earnings, APTD or FBT? Aptitude Software Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Aptitude Software Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptitude Software Group£69.26M2.14£4.65M£8.4431.62First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,364.91 Does the media prefer APTD or FBT? In the previous week, Aptitude Software Group had 3 more articles in the media than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. MarketBeat recorded 3 mentions for Aptitude Software Group and 0 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's average media sentiment score of 1.69 beat Aptitude Software Group's score of 0.56 indicating that First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is being referred to more favorably in the news media. Company Overall Sentiment Aptitude Software Group Positive First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Very Positive Do analysts rate APTD or FBT? Aptitude Software Group presently has a consensus target price of GBX 445, indicating a potential upside of 66.67%. Given Aptitude Software Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Aptitude Software Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptitude Software Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in APTD or FBT? 76.0% of Aptitude Software Group shares are owned by institutional investors. 8.6% of Aptitude Software Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is APTD or FBT more profitable? Aptitude Software Group has a net margin of 6.71% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. Aptitude Software Group's return on equity of 8.16% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.Company Net Margins Return on Equity Return on Assets Aptitude Software Group6.71% 8.16% 3.49% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation N/A N/A N/A SummaryAptitude Software Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 12 of the 13 factors compared between the two stocks. Get Aptitude Software Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APTD and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APTD vs. The Competition Export to ExcelMetricAptitude Software GroupSoftware IndustryComputer SectorLON ExchangeMarket Cap£148.12M£6.36B£29.98B£3.09BDividend Yield1.63%3.24%3.09%5.04%P/E Ratio31.6228.5151.55174.55Price / Sales2.14271.171,326.36282,771.03Price / Cash8.5417.1836.2727.94Price / Book2.6410.649.485.38Net Income£4.65M£49.83M£803.97M£5.89B7 Day Performance-4.64%-1.95%1.00%-0.15%1 Month Performance-13.31%-0.77%0.15%0.99%1 Year Performance-25.83%7.60%23,893.80%64.40% Aptitude Software Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTDAptitude Software Group2.7718 of 5 starsGBX 267flatGBX 445+66.7%-24.7%£148.12M£69.26M31.62452Gap UpFBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,525.80+0.6%N/A-5.8%£625.91MN/A-1,387.0920News CoverageGBGGB Group2.4304 of 5 starsGBX 226+1.1%GBX 390+72.6%-34.8%£570.03M£276.95M-11.731,183Gap UpIMOIMImobileN/AN/AN/AN/A£490.40M£164.04M123.755,300NCCNCC Group1.4572 of 5 starsGBX 145.40-1.0%GBX 175+20.4%-9.6%£458.41M£326.70M-18.312,200Dividend CutCERCerillionN/AGBX 1,520-1.3%GBX 2,350+54.6%-21.0%£450.76M£41.39M32.04321Dividend IncreaseATGAuction Technology Group2.1351 of 5 starsGBX 350-4.8%GBX 695+98.6%-21.5%£432.37M£136.68M42.75396IQGIQGeo GroupN/AN/AN/AN/A£295.50M£44.48M-20,700.00217IDOXIDOX2.5109 of 5 starsGBX 62.49+0.8%GBX 85.50+36.8%-3.3%£285.75M£81.51M51.57626Positive NewsBIGBig Technologies1.1104 of 5 starsGBX 92.20+1.3%GBX 80-13.2%-24.3%£261.89M£53.85M20.6436,200ACSOaccesso Technology Group3.5695 of 5 starsGBX 440+0.2%GBX 562.50+27.8%-18.1%£219.34M£188.60M25.68672 Related Companies and Tools Related Companies First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Alternatives GB Group Alternatives IMImobile Alternatives NCC Group Alternatives Cerillion Alternatives Auction Technology Group Alternatives IQGeo Group Alternatives IDOX Alternatives Big Technologies Alternatives accesso Technology Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:APTD) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptitude Software Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptitude Software Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access